HEATHER WONG: Open Payments
NPI 1104367846 · ONTARIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $166 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $154 |
| Supernus Pharmaceuticals, Inc. | 7 | $137 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| ABBVIE INC. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Indivior Inc. | 2 | $30 |
| Braeburn Inc. | 1 | $25 |
Products named: COBENFY, CAPLYTA, Auvelity, VRAYLAR, REXULTI, SUBLOCADE, BRIXADI.
Industry payments across CA — which companies pay providers there.
